Skip to main content
Clinical Trials/NCT01396993
NCT01396993
Unknown
Not Applicable

Prospective Trial Evaluating Cosmetic And Oncologic Outcome Of Immediate Techniques For Oncoplastic Surgery In Breast Cancer

Medical University of Vienna1 site in 1 country150 target enrollmentJuly 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Image Scale Index for Self Esteem Evaluation
Sponsor
Medical University of Vienna
Enrollment
150
Locations
1
Primary Endpoint
breast image scale
Last Updated
10 years ago

Overview

Brief Summary

Breast conserving therapy (BCT) is the standard treatment for intraductal or invasive breast cancer patients. However cosmetic results, e.g. symmetry and nipple displacement, are sometimes poor reducing the quality of life. The use of immediate techniques for oncoplastic surgery (iTOP) seems to improve subjective cosmetic outcome. Oncologic safety of iTOP has been demonstrated by several authors using restrospective analyses. However, no prospective observational trial has been done to objectively evaluate cosmetic and oncologic outcome comparing BCT with iTOP. The aim of this study is to investigate this issue within a prospective non randomized observational trial at the Medical University Vienna.

Registry
clinicaltrials.gov
Start Date
July 2011
End Date
August 2016
Last Updated
10 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Florian Fitzal

Professor of Surgery

Medical University of Vienna

Eligibility Criteria

Inclusion Criteria

  • Patients scheduled for unilateral breast conserving surgery due to cancer or a suspicious lesion, in whom \>10%\* of breast volume (measured by mammograms using a defined formular 37) has to be removed or breast cancer patients scheduled for mastectomy and immediate reconstruction (immediate or delayed contralateral correction is allowed)
  • BIRADS IV, V or VI are eligible
  • \> 18 years of age
  • Psychological and physical capable of understanding and performing the trial
  • Signed written informed consent \* If oncologic safety necessitates to resect more than half of one breast quadrant

Exclusion Criteria

  • Inflammatory breast cancer
  • Progression after neoadjuvant therapy
  • Pregnant women
  • Patients unable to perform surgery under general anaesthesia
  • Bilateral breast lesions

Outcomes

Primary Outcomes

breast image scale

Time Frame: 2 years

self esteem measured by the breast image scale will be assessed before and every 6 months after surgery as primary endpoint.

Secondary Outcomes

  • Morbidity(6 months)
  • breast symmetry index(2 years)
  • oncologic parameters(2-5 years)
  • quality of life(2 years)

Study Sites (1)

Loading locations...

Similar Trials